Combined Invasive Subcortical and Non-invasive Surface Neurophysiological Recordings for the Assessment of Cognitive and Emotional Functions in Humans.
In spite of the success in applying non-invasive electroencephalography (EEG), magneto-encephalography (MEG) and functional magnetic resonance imaging (fMRI) for extracting crucial information about the mechanism of the human brain, such methods remain insufficient to provide information about physiological processes reflecting cognitive and emotional functions at the subcortical level. In this respect, modern invasive clinical approaches in humans, such as deep brain stimulation (DBS), offer a tremendous possibility to record subcortical brain activity, namely local field potentials (LFPs) representing coherent activity of neural assemblies from localized basal ganglia or thalamic regions. Notwithstanding the fact that invasive approaches in humans are applied only after medical indication and thus recorded data correspond to altered brain circuits, valuable insight can be gained regarding the presence of intact brain functions in relation to brain oscillatory activity and the pathophysiology of disorders in response to experimental cognitive paradigms. In this direction, a growing number of DBS studies in patients with Parkinson's disease (PD) target not only motor functions but also higher level processes such as emotions, decision-making, attention, memory and sensory perception. Recent clinical trials also emphasize the role of DBS as an alternative treatment in neuropsychiatric disorders ranging from obsessive compulsive disorder (OCD) to chronic disorders of consciousness (DOC). Consequently, we focus on the use of combined invasive (LFP) and non-invasive (EEG) human brain recordings in assessing the role of cortical-subcortical structures in cognitive and emotional processing trough experimental paradigms (e.g. speech stimuli with emotional connotation or paradigms of cognitive control such as the Flanker task), for patients undergoing DBS treatment.
Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich-Heine-University.
Carlos
C
Trenado
Department of Neurology, Center for Movement Disorders and Neuromodulation, University Clinic Düsseldorf.
Saskia
S
Elben
Department of Neurology, Center for Movement Disorders and Neuromodulation, University Clinic Düsseldorf.
David
D
Petri
Department of Neurology, Center for Movement Disorders and Neuromodulation, University Clinic Düsseldorf.
Jan
J
Hirschmann
Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich-Heine-University; Department of Neurology, Center for Movement Disorders and Neuromodulation, University Clinic Düsseldorf.
Stefan J
SJ
Groiss
Department of Neurosurgery, Functional Neurosurgery and Stereotaxy, Center for Movement Disorders and Neuromodulation, University Clinic Düsseldorf.
Jan
J
Vesper
Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich-Heine-University; Department of Neurology, Center for Movement Disorders and Neuromodulation, University Clinic Düsseldorf.
Alfons
A
Schnitzler
Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich-Heine-University; Department of Neurology, Center for Movement Disorders and Neuromodulation, University Clinic Düsseldorf; lars.wojtecki@med.uni-duesseldorf.de.
Lars
L
Wojtecki
D003071:Cognition; D046690:Deep Brain Stimulation; D004644:Emotions; D006801:Humans; D008991:Monitoring, Physiologic; D010300:Parkinson Disease / Q000503:physiopathology / Q000628:therapy; D013788:Thalamus